On 2025-05-08, Rapt Therapeutics (RAPT) announced earnings per share of $-0.64 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-2.48.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.69 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-2.48 | $-0.64 |
| 2025-03-06 | 2024-12-31 | $-3.60 | $-9.12 |
| 2024-11-12 | 2024-09-30 | $-4.48 | $-3.76 |
| 2024-08-08 | 2024-06-30 | $-5.92 | $-5.68 |
| 2024-05-09 | 2024-03-31 | $-6.24 | $-6.32 |
| 2024-03-07 | 2023-12-31 | $-6.80 | $-6.40 |
| 2023-11-13 | 2023-09-30 | $-6.00 | $-6.56 |
| 2023-08-11 | 2023-06-30 | $-6.40 | $-5.28 |
| 2023-05-11 | 2023-03-31 | $-5.12 | $-6.08 |
| 2023-03-14 | 2022-12-31 | $-5.36 | $-5.12 |
| 2022-11-10 | 2022-09-30 | $-5.20 | $-5.04 |
| 2022-08-11 | 2022-06-30 | $-6.00 | $-4.96 |
| 2022-05-11 | 2022-03-31 | $-5.28 | $-5.52 |
| 2022-03-10 | 2021-12-31 | $-5.28 | $-4.88 |
| 2021-11-10 | 2021-09-30 | $-4.80 | $-5.04 |
| 2021-08-11 | 2021-06-30 | $-4.96 | $-5.04 |
| 2021-05-11 | 2021-03-31 | $-4.16 | $-5.28 |
| 2021-03-11 | 2020-12-31 | $-4.32 | $-4.16 |
| 2020-11-16 | 2020-09-30 | $-3.92 | $-4.80 |
| 2020-08-13 | 2020-06-30 | $-3.92 | $-4.08 |
| 2020-05-14 | 2020-03-31 | $-3.92 | $-4.48 |
| 2020-03-30 | 2019-12-31 | -- | $-6.96 |
| 2019-12-11 | 2019-09-30 | -- | $-99.28 |